📢 Exciting news for the Life Sciences Community! Life Sciences Ontario, in collaboration with Shift Health, Pfizer and adMare BioInnovations, is proud to announce the publication of “Status of Inclusion, Diversity, Equity and Accessibility (IDEA) in Canada's Life Sciences Sector.” This comprehensive report provides insights into progress, challenges, and opportunities for fostering a more inclusive, diverse and accessible industry and is informed by the findings from a national survey of life sciences organizations and focus groups with diverse individuals working in the sector. Shift Health and Life Sciences Ontario extend their sincere thanks to Pfizer and adMare BioInnovations for funding this study. We also extend deep gratitude to all who participated in the survey and focus groups. You can read the report here: https://lnkd.in/gX_TiAr8 You can read the press release here: https://lnkd.in/ggSBzZ4m #StatusofIDEA #lifesciences #inclusion #diversity #equity #accessibility #canada
Life Sciences Ontario
Biotechnology Research
Toronto, Ontario 12,383 followers
A member-funded, not-for-profit advancing life sciences through advocacy, education, mentorship and networking.
About us
The Voice of Life Sciences in Ontario. As companies and stakeholders look for a definitive voice in the Life Science arena in Ontario they will look to LSO not only for the directions and resolutions to public policy issues, but also to be the conduit between the many organizations in Ontario and the governments that operate in our space. LSO will work in concert with life science companies and organizations to grow the sector in Ontario and maintain our position on the global arena. LSO will maintain their status of no government funding and will continue to grow through its value proposition to members, stakeholders and governments. We will complement, not compete with, the work of our stakeholders. LSO events are targeted to specific stakeholders groups and are must attend. Organizations will want to partner with LSO due to its commitment to the sector and its ability to deliver.
- Website
-
http://www.lifesciencesontario.ca
External link for Life Sciences Ontario
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Toronto, Ontario
- Type
- Nonprofit
- Specialties
- Advocacy, Marketing/promoting, Facilitation of Investment and Partnering, and Education
Locations
-
Primary
Get directions
162 Cumberland Street
310
Toronto, Ontario M5R 3NS, CA
Employees at Life Sciences Ontario
-
Darren Anderson
CEO at Vive Crop Protection
-
Pamela Kanellis
-
Andy Donovan
Sales professional and agent of connectivity within the life sciences sector.
-
Sanjay Kumar Aggarwal
Need a Technology Partner? 20 Years of Building Web & Mobile Apps for Startups, Individuals, and SMBs with a Team of 40 Developers | Built & Grown…
Updates
-
LSO is a 100% member-funded organization, and all the work we do is possible because of our members' support. We'd like to welcome more organizations that joined us this year. BridgeBright Search and Advisory; CTI Working Environments Inc.; Curious Public; Element Materials Technology; Idorsia Pharmaceuticals Canada Ltd.; Invest Barrie; MIDI Product Development; Next Vision Healthcare Consulting ™️; ramarketing; and Tekama Advisory. We look forward to collaborating with these organizations to drive prosperity in the #lifesciences sector. Stay tuned for more new members in the coming weeks. In the meantime, you can read more about our members here: https://lnkd.in/gEa5uSu5
-
-
This is amazing news for Canadian residents and our #lifesciences sector. Congratulations to Kye Pharmaceuticals on this amazing accomplishment! 🎉 You can read the full press release here: https://lnkd.in/gUNvTG35 #pharmaceuticals #announcement #congrats #canada
The first-and-only extended-release chewable methylphenidate tablets approved by Health Canada. QUILLIVANT® ER Chewable Tablets are now available in Canada! Great news for many young people across Canada, and a terrific milestone for the team at Kye Pharmaceuticals. #Kyeproud
-
Check out the upcoming courses and events being coordinated by our friends at PSG Pharmaceutical Sciences Group. cc Amanda Wright https://lnkd.in/gpjJzxbs
-
-
Great news from one of our newest members Kye Pharmaceuticals! https://lnkd.in/gUNvTG35
The first-and-only extended-release chewable methylphenidate tablets approved by Health Canada. QUILLIVANT® ER Chewable Tablets are now available in Canada! Great news for many young people across Canada, and a terrific milestone for the team at Kye Pharmaceuticals. #Kyeproud
-
The Future Economy published “Can Canada Harness Its Potential to Become a Leader in the Life Sciences?”, an op-ed penned by Dr. Jason Field, President and CEO of Life Sciences Ontario. This piece delves into Canadian leadership in the life sciences and obstacles to overcome; it also emphasizes the acute need for collaboration and an all-hands-on-deck approach. “Canada now faces a crucial choice,” says Dr. Jason Field. “It can ignore or fight these technological advances by shutting the door to healthcare innovation and concluding that what we do now is “good enough.” The other option is to embrace the dramatic changes in science and healthcare and harness them for the benefit of both patients and our economic development.” Read this op-ed and be part of an important conversation which will shape the future of Canada’s life sciences sector: https://lnkd.in/ggVJ-zrG
-
Inteligex another example of a Toronto based company doing great things! Learn more about their regenerative stem cell therapeutics.
𝐒𝐩𝐢𝐧𝐚𝐥 𝐂𝐨𝐫𝐝 𝐈𝐧𝐣𝐮𝐫𝐲 𝐈𝐧𝐯𝐞𝐬𝐭𝐨𝐫 𝐒𝐲𝐦𝐩𝐨𝐬𝐢𝐮𝐦: Inteligex CEO Paul Bradshaw on stem cells that are designed to account for regional identity differences within the spinal cord, and also engineering in a proliferation factor. He explains how Inteligex's "ReStaRT Cells" are designed with a regional identity, and the rationale for engineering them to express the ChABC and GDNF genes to boost the odds of survival and proliferation. Full video: https://lnkd.in/gvuKf98G BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
-
🎉 Meet Our Newest Members 🎉 We are thrilled to introduce another group of organizations that joined the LSO community this year. Join us to welcome these trailblazing companies: 🌟CGI; GE HealthCare; HUB International, Intrepid Labs; Northwest Value Partners Inc.; Prudential Overall Supply; QReserve; Santis Health; Seaford Pharmaceuticals Inc.; and SIGNAL Underwriting 🌟 We look forward to collaborating with them as we continue to advocate for the advancement of Ontario's #lifesciences sector! You can learn more about these organizations by visiting our member directory: https://lnkd.in/gEa5uSu5 #innovation #newmembers #community #ontario
-
-
🎉 Meet Our Newest Members 🎉 We are thrilled to introduce and welcome some of the latest additions to our growing community. These innovative companies are driving progress and making significant contributions to the life sciences sector. 🌟 ACROBiosystems, Allyant , Bruce Power, Cambrian College, Canadore College, Daiichi Sankyo US, Eisai Co., Ltd., Moderna, Shoppers Drug Mart Specialty Health Network, Stem Cell Network 🌟 Together, we are fostering a vibrant ecosystem that supports the advancement and a brighter future for #lifesciences in Ontario! You can learn more about these organizations by visiting our member directory: https://lnkd.in/gEa5uSu5 #innovation #healthcare #newmembers #community #ontario
-
-
Life Sciences Ontario reposted this
Strategic expertise in bringing innovation in the life sciences to support the Canadian bio-economy.
Great conversation at the Life Sciences Ontario knowledge and networking breakfast with Maura Campbell (OBIO) Garrett Tone (Invest Ontario) Michael Midmer (Zucara Therapeutics Inc. ) Nabanita Nawar, PhD (HDAX Therapeutics ) Adam Thompson (BDO) on fostering a competitive landscape in Ontario.
-